Natural Supplements for NHL
Top natural supplements to help with Non-Hodgkins Lymphoma, be sure to talk to your doctor about these supplements:
"Non-Hodgkin’s lymphoma symptoms are very similar to that of Hodgkin's disease (HD). Most non-Hodgkin’s lymphoma symptoms can be confused with other day-to-day ailments. People with multiple of the following symptoms should consult a doctor to ensure they are not a result of non-Hodgkin’s lymphoma.
One of the most common symptoms of non-Hodgkin's lymphoma is painless swelling in the lymph nodes. If you see swelling without pain around the collarbone region, groin, armpits, and neck, you should pay special attention to these symptoms.
Although swelling of the lymph nodes is a common symptom of non-Hodgkin's lymphoma, this swelling may also be due to an infection. Upon seeing such symptoms, one should opt for a biopsy in order to ensure that the disease is tackled at the very first stage. These signs are also close to Hodgkin's disease symptoms.
Read More: http://www.newsmax.com/FastFeatures/non-hodgkins-lymphoma-treatment/2010...
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
